Evidence map›Paper›PMID 31924145›Full record

SynthesisLupus2020

Mobile health technologies for the management of systemic lupus erythematosus: a systematic review.

L O Dantas, S Weber, M C Osani, R R Bannuru, T E McAlindon, S Kasturi

Abstract readSystematic Review
In one paragraph

Synthesis in Lupus, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

L O DantasDivision of Rheumatology, Allergy and Immunology, Tufts Medical Center, Boston, Massachusetts, USA.
S WeberDivision of Rheumatology, Allergy and Immunology, Tufts Medical Center, Boston, Massachusetts, USA.
M C OsaniCenter for Treatment Comparison and Integrative Analysis, Division of Rheumatology, Allergy and Immunology, Tufts Medical Center, Boston, Massachusetts, USA.
R R BannuruCenter for Treatment Comparison and Integrative Analysis, Division of Rheumatology, Allergy and Immunology, Tufts Medical Center, Boston, Massachusetts, USA.
T E McAlindonDivision of Rheumatology, Allergy and Immunology, Tufts Medical Center, Boston, Massachusetts, USA.
S KasturiDivision of Rheumatology, Allergy and Immunology, Tufts Medical Center, Boston, Massachusetts, USA.ORCID https://orcid.org/0000-0001-8496-5595

Funding

CTSA Institutional Mentored Career Development Program (KL2)KL2TR002545 · NCATS · TUFTS UNIVERSITY BOSTON · PI FREUND, KAREN · 2018 to 2022
$5.0M
Comparative effectiveness of mind-body interventions for osteoarthritis - individual patient data network meta-analysisK23AT009374 · NCCIH · TUFTS MEDICAL CENTER · PI BANNURU, RAVEENDHARA REDDY · 2017 to 2021
$830k
NCATS NIH HHS KL2 TR002545NCCIH NIH HHS K23 AT009374
6 · The paper itself

Abstract

objectiveWe aimed to perform a standardized review of available mobile health (mHealth) applications (apps) for systemic lupus erythematosus (SLE) and to conduct a systematic review of the literature on mHealth technologies in SLE.

methodsGoogle Play and AppStore in the United States of America were queried and the quality of eligible mHealth apps was assessed using the Mobile App Rating Scale (MARS). Web of Science, EMBASE, Medline, and Cochrane databases were systematically searched from inception through June 2019.

resultsOf 324 mHealth apps found, 20 were eligible for inclusion; 10 focused on education, 7 offered tools to track patient-reported symptoms, 5 included interactive online communities, and 1 enabled emoji sharing. The reviewed apps scored poorly on the MARS quality scale with a mean score 2.3 (0.6) out of 5. Of 1147 studies identified in the literature review, 21 were eligible for inclusion; 11 studies (52.4%) focused on the development and use of mHealth for providing patient information, while only 2 (9.5%) were randomized trials of mHealth interventions.

conclusionsAlthough there is growing interest in the development of mHealth technologies to support SLE patients, currently available tools are of poor quality and limited functionality, and the literature examining this area is sparse.

Indexed as

Mobile ApplicationsHumansLupus Erythematosus, SystemicQuality of LifeRandomized Controlled Trials as TopicTelemedicineTreatment OutcomeChronic diseasemHealthmobile health technologysystemic lupus erythematosustechnology

Identifiers

PMID31924145
PMCPMC6992477

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.